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AMP-activated protein kinase (AMPK) has attracted much attention for its key role in energy homeo-
stasis. Three new papers providing structural information on mammalian and yeast AMPK homologs
give insights into the binding of the regulatory nucleotides AMP and ATP and how mutations are
associated with cardiac glycogen storage disorders.
Open access under CC BY license.In mammals, metabolic stresses that in-
hibit ATP synthesis (e.g., hypoglycemia)
or accelerate ATP consumption (e.g.,
muscle contraction) cause increases
in the cellular AMP:ATP ratio that acti-
vate the AMP-activated protein kinase
(AMPK) system. AMPK protects cells
against such stresses by activating al-
ternate catabolic pathways and inhibit-
ing cell growth and division. This cellular
energy-sensing role is most likely the
function for which the AMPK system
originally evolved. However, in multicel-
lular organisms it also plays a key role
in the regulation of whole-body energy
balance, being involved in the control
of food intake and energy expenditure
by mediating effects of hormones like
leptin and adiponectin (Kahn et al.,
2005). Three new papers (Amodeo
et al., 2007; Townley and Shapiro, 2007;
Xiao et al., 2007) provide important
structural information about AMPK
and its yeast homologs.
AMPK exists as heterotrimeric com-
plexes containing a catalytic a subunit
and regulatory b and g subunits. Bind-
ing of AMP to two domains on the g
subunit (Scott et al., 2004) activates
the kinase both by direct allosteric
activation and by inhibiting dephos-
phorylation of an activating site on
the a subunit, effects that are antago-
nized by ATP (Hardie, 2007). Genes
encoding a, b, and g subunit orthologs
are found in almost all eukaryotes. The
role of the budding yeast Saccharo-
myces cerevisiae AMPK ortholog (the
SNF1 complex) is known from genetic
studies, being required for the re-
sponse to glucose starvation, a stress
that causes activation of the kinase
and correlates with dramatic increases
in cellular AMP:ATP (Wilson et al.,
1996). Surprisingly, however, attemptsto demonstrate activation of the yeast
complex by AMP have so far failed.
The new reports provide structures
for the ‘‘core’’ of the abg complex from
mammals and budding yeast (Xiao
et al., 2007; Amodeo et al., 2007) that
were solved by molecular replacement
using a recent structure from the
distantly related fission yeast Schizo-
saccharomyces pombe (Townley and
Shapiro, 2007). Unfortunately, the
complete abg complexes failed to
crystallize, and the mammalian and fis-
sion yeast structures, while containing
the entire g subunits, only have the C-
terminal regionsof theaandbsubunits.
The budding yeast structure also con-
tains the b subunit glycogen-binding
domain and a small additional region
of a (Figure 1A), but all three structures
lack the kinase domain. Despite the
fact that neither of the yeast kinases
appears to be activated by AMP, they
were nevertheless crystallized in the
presence of the nucleotide, and AMP
was found to be present in the crystals.
The structures of the three core
complexes are very similar. The C-ter-
minal region of the a subunit forms
a compact domain around which the
C-terminal region of the b subunit is
wrapped. The main contact between
this ab complex and the g subunit is
via an intersubunit b sheet, of which
the C-terminal end of the b subunit pro-
vides two strands and the g subunit the
third. It had previously been proposed
that each of the two AMP-binding do-
mains in the g subunit (termed Bate-
man domains) is formed by association
of two sequence repeats known as
cystathionineb-synthase (CBS) motifs,
with the clefts between the repeats
providing the nucleotide-binding sites
(Scott et al., 2004). While this idea hasCell Metabolism 6,now been confirmed, the new struc-
tures also show that the two Bateman
domains associate together in a pseu-
dosymmetrical head-to-head arrange-
ment, forming a flattened disk with
a small solvent-accessible channel
through the center that would potentially
allow access of nucleotides from either
side (Figure 1A). The nucleotides bind
with their phosphate groups in this cen-
tral channel. An interesting feature of
this arrangement is that residues in one
Bateman domain contribute to binding
of nucleotide in the other (Figure 1B).
Because the two CBS motifs in each
Bateman domain also associate to-
gether in a pseudosymmetrical man-
ner, there are two potential nucleo-
tide-binding sites in each domain,
making four in each g subunit. AMP oc-
cupies three of these in the mammalian
structure, one in fission yeast, and
none in budding yeast (although low-
resolution data on a second crystal
suggested the presence of one AMP
in the same position as in fission yeast).
The results with the mammalian com-
plex were surprising because it has
previously been proposed that the g
subunits bind only two molecules of
each nucleotide (Scott et al., 2004).
However, new binding studies with
the mammalian abg complex confirm
that only two bind reversibly (Xiao
et al., 2007). This suggests that the
third AMP is tightly bound and non-
exchangeable, an idea supported by
two additional findings: (1) the mam-
malian complex expressed in bacteria
already contained one mole of bound
nucleotide per mole of protein, primar-
ily AMP, and (2) when ATP was soaked
into crystals containing AMP, it re-
placed AMP at only two of the three
sites (Xiao et al., 2007). The remainingNovember 2007 ª2007 Elsevier Inc. 339
Cell Metabolism
PreviewsFigure 1. Structures of AMPK and Its Homologs
(A) Cartoon view of the S. cerevisiae structure (Protein Data Bank ID code 2QLV) illustrating the
general layout of the secondary structural elements. The dotted lines represent two of the three
axes about which the cystathionine b-synthase (CBS) motifs of the g subunits show approximate
two-fold symmetry. The three-stranded b sheet connecting the b and g subunits, the solvent-
accessible channel through the g subunit, and the clefts where AMP binds in mammalian AMPK
between CBS1/CBS2 (N-terminal Bateman domain) and CBS3/CBS4 (C-terminal Bateman
domain) are indicated. Key: a-CTD and a (460–498), Snf1 C-terminal domain and residues
460–498 (shown in yellow); b-CTD, Sip2 C-terminal domain (red); b-GBD, Sip2 glycogen-binding
domain (green); g-NTD, Snf4 N-terminal domain (tan); g-CBS1/2/3/4, Snf4 CBS motifs 1/2/3/4
(1, light blue; 2, purple; 3, dark blue; 4, orange).
(B) ‘‘Stick’’ view (C atoms shown in green; N, blue; P, orange; O, red) of AMP1 and AMP3 (in the
CBS3:CBS4 cleft) and AMP2 (in the CBS1:CBS2 cleft) in the mammalian a1b2g1 complex (PDB
ID code 2V8Q). Basic residues (using g2 numbering) that interact with the phosphate groups of
AMP or ATP are also shown. Interestingly, H383 (in CBS2) interacts with AMP molecules bound to
both Bateman domains, while R302 (in CBS1) interacts with AMP in the other Bateman domain.
R384 does not interactwithAMPbutdoes interactwith ATPwhen it replacesAMP2 (Xiao et al., 2007).
Figures were generated using MacPyMOL.AMP was bound in the same position
as the single molecule observed in
the yeast structures. The fourth poten-
tial site may be unoccupied in the
human g subunit because aspartate
residues whose side chains interact
with the 20 and 30 hydroxyls of the
AMP ribose in the other three sites
(D89, D244, and D316) are replaced
by an arginine (R170). These residues
are highly conserved in all eukaryotes.
Point mutations of up to ten different
residues in the g2 isoform of mammalian
AMPK cause heart disease character-
ized by excessive glycogen storage in
cardiac myocytes, with the key clinical
feature being ventricular pre-excitation
(Akman et al., 2007; Arad et al., 2007). A
transgenic mouse model has suggested
that the elevatedglycogen storage is due
to increased basal activity of the mu-
tant complex, leading to increased glu-
cose uptake in the absence of increased
energy demand (Luptak et al., 2007). The
disease-causing mutations all reduce
binding and activation by AMP (Scott
et al., 2004), but the increased basal340 Cell Metabolism 6, November 2007 ªactivity is likely due to failure to bind the
inhibitory nucleotide, ATP (Burwinkel
et al., 2005). Satisfyingly, nine of the
ten residues affected by the disease lie
very close to the AMP/ATP binding
sites, and six (including four basic resi-
dues, R302, H383, R384, and R531, hu-
mang2numbering)makedirectcontact
with the nucleotides (Figure 1B). These
six residues are conserved in all known
vertebrate and invertebrate g subunits,
but R302 and H383 are not conserved
in the yeast sequences. Since these
two residues are involved in binding
the two exchangeable molecules of
AMP (Figure 1B), this may explain why
AMP does not activate the yeast com-
plexes. However, thisbegs the question
as to why the latter still have Bateman
domains that bind a single molecule of
AMP.
The budding yeast structure contains
a small additional region of the a sub-
unit that interacts with the g subunit
and has been proposed to play a reg-
ulatory role (Jiang and Carlson, 1996).
However, the explanation as to how2007 Elsevier Inc.AMP activates the mammalian kinase,
while ATP inhibits it, remains elusive.
There is no major change in conforma-
tion between the complexes containing
ATP versus AMP, although the nucleo-
tide phosphate groups are partially
exposedtosolvent, thusalteringthedis-
tribution of surface charge. Xiao et al.
(2007) propose that this may cause
changes in interactions with the a or b
subunits. However, none of the new
structures contains the kinase domain,
so its crucial interactions with the other
domains remain unclear. With a system
so exquisitely regulated, it was perhaps
inevitable that even three new struc-
tures (plus previous structures of the
isolated kinase, glycogen-binding, and
Bateman domains) would not provide
all of the answers. Explaining how AMP
regulates kinase activity and dephos-
phorylation remains an important chal-
lenge for the future.
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